The capacities of citrus fruits to inhibit midazolam 1Ј-hydroxylase activity of cytochrome P450 3A (CYP3A) expressed in human liver microsomes were evaluated. Eight citrus fruits such as ama-natsu, banpeiyu, Dekopon, hassaku, hyuga-natsu, completely matured kinkan (Tamatama), takaoka-buntan and unshu-mikan were tested. We also examined the inhibition of CYP3A activity by grapefruit (white) and grapefruit juice (white, TropicanaKirin). The addition of a fruit juice prepared from banpeiyu, hassaku, takaoka-buntan or Tamatama caused the inhibition of the microsomal CYP3A activity. The inhibition depended on the amount of a fruit juice added to the incubation mixture (2.5 and 5.0%, v/v). The fruit juice from banpeiyu showed the most potent inhibition of CYP3A. The addition of a banpeiyu juice (5.0%, v/v) resulted in the inhibition of midazolam 1Ј-hydroxylase activity to about 20% of control without a fruit juice. The elongation of the preincubation period of a fruit juice from banpeiyu (5.0%, v/v) with the microsomal fraction (5 to 15 min) led to the enhancement of the CYP3A inhibition (5% of control). Thus, we discovered ingredients of banpeiyu to be inhibitor(s) or mechanism-based inhibitor(s) of human CYP3A activity, but the inhibitory effects of them were somewhat lower than those of grapefruit.
Grapefruit juice has been taken by many people living in all over the world. In early 1990's, grapefruit juice was documented to affect the oral bioavailability of felodipine. 1, 2) The mean bioavailability of felodipine administered with grapefruit juice was more than 250% that with water. The diastolic blood pressure was lower and the heart rate was higher than those seen with water. Adverse experiences, mainly accounted for by headaches, facial flushing and lightheadedness, were reported to be more frequent after intake of grapefruit juice than water. Subsequently, various drugs which were orally administered have been proven to interact with grapefruit juice. [3] [4] [5] [6] [7] [8] These drugs differ in their chemical structure and pharmacological properties, but are commonly metabolized by a form of cytochrome P450, 9) namely cytochrome P450 3A4 (CYP3A4). Studies performed by Fukuda et al., 10, 11) Guo et al. 12) and Tassaneeyakul et al. 13) have shown that the furanocoumarin derivatives identified from grapefruit juice strongly inhibited the catalytic activity of CYP3A4, and caused the decrease of the first pass metabolism of orally administered drugs by CYP3A4. Subsequent studies have demonstrated that grapefruit juice resulted in the loss of intestinal CYP3A4 protein without changing the specific mRNA levels. 14, 15) On the other hand, common orange juice has been documented that it is incapable of inhibiting the catalytic activity of CYP3A4.
2) Taking these results into account, the inhibitory effects of citrus fruits appeared to depend on the fruit species because of the difference of the components contained in each of a citrus fruit. 2, 12) Miyazaki prefecture is located at the southern part of Kyushu Island in Japan. A vast array of citrus fruits have been produced in Miyazaki area because of its warm climate. The citrus fruits are taken by many people living not only in the area but also in the other regions around there, especially in winter and spring seasons.
So far, there has been no report on the effects of these citrus fruits on human cytochrome P450 3A (CYP3A) activity.
Therefore, in the present study, we investigated whether the components present in the citrus fruits inhibited the CYP3A activity. The ability of ingredients of the fruits to inhibit the midazolam 1Ј-hydroxylase activity of human CYP3A was examined by using human liver microsomes.
MATERIALS AND METHODS
Chemicals Glucose 6-phosphate, glucose 6-phosphate dehydrogenase and NADP ϩ were obtained from Oriental Yeast (Tokyo, Japan). 1Ј-Hydroxymidazolam and midazolam were from Wako Pure Chemicals (Tokyo, Japan). Pooled human liver microsomes were purchased from Daiichi Pure Chemicals (Tokyo, Japan). All other chemicals and solvents were of the highest grade commercially available.
Samples of Fruits and Juice Citrus fruits, ama-natsu, banpeiyu, Dekopon, hassaku, hyuga-natsu, completely matured kinkan (Tamatama), takaoka-buntan, unshu-mikan, grapefruit (white), grapefruit juice (white, Tropicana-Kirin) and navel orange were obtained from local commercial sources and their available information is shown in Table 1 . All the fruit samples and grapefruit juice sample were tested soon after they were squeezed and filtered or the juice package was opened.
Assay of Midazolam 1Ј-Hydroxylase Activity of Human CYP3A A typical incubation mixture consisted of 100 mM sodium potassium phosphate buffer (pH 7.4), 50 mM EDTA disodium salt, an NADPH-generating system (0.5 mM NADP ϩ , 5 mM MgCl 2 , 5 mM glucose 6-phosphate and 1 unit/ml glucose 6-phosphate dehydrogenase), and microsomal fraction of the human liver in a final volume of 0.5 ml. The concentration of midazolam was 10 mM. Reactions were initiated by the addition of midazolam. After incubation at 37°C for 2 min, 5 ml of ethyl acetate was added to stop the reaction. Five hundred picomoles of clonazepam was added as an internal standard. The mixture was extracted with ethyl acetate and centrifuged at 3000 rpm for 10 min. The organic layer was transferred to another tube and the solvent was evaporated. The residue was dissolved in 10 mM sodium acetate, methanol and acetonitrile (9 : 1 : 1, v/v) (200 ml). Analysis of the 1Ј-hydroxymidazolam metabolite was performed by HPLC using a computerized HPLC system (Shimadzu model LC10A series, Shimadzu, Kyoto, Japan) equipped with a TSK-gel ODS-120T analytical column (4.6ϫ150 mm; 4 mm; TOSOH, Tokyo, Japan). The mobile phase consisted of 10 mM sodium acetate, methanol and acetonitrile (9 : 1 : 1, v/v) for solvent A and methanol and acetonitrile (2 : 1, v/v) for solvent B. The metabolite was separated using a linear gradient of 70% to 50% solvent A, 0 to 25 min, at a flow rate of 1.0 ml/min. Quantification of the metabolite was performed by comparing the HPLC peak area monitored at 240 nm to that of the internal standard.
Inhibitory Effects of Citrus Fruits on CYP3A Activity The inhibitory effects of citrus fruits on CYP3A activity were investigated according to the method of Guo et al. 12) with minor modifications. Briefly, a citrus fruit juice (12.5 or 25.0 ml) was dried with a concentrator. The reaction mixture, before the addition of midazolam, described above was added and the residue of the citrus fruits was resuspended with a vortex mixer. After a preincubation of the mixture at 37°C for 5 min, the substrate midazolam was added. The reaction was performed as mentioned above. The inhibitory effect of citrus fruit on midazolam 1Ј-hydroxylation was expressed as a percentage of the residual activity compared with the control.
Effects of Preincubation of Citrus Fruits on Human CYP3A Activity As an index of a mechanism-based inhibition, a citrus fruit juice was preincubated at 37°C for 15 min in the reaction mixture according to the method mentioned above.
RESULTS AND DISCUSSION
Inhibition of midazolam 1Ј-hydroxylase activity of human CYP3A by ingredients of various citrus fruits was examined. The inhibition of human CYP3A by a juice prepared from each of a citrus fruit is summarized in Table 2 . The addition of a fruit juice prepared from banpeiyu, hassaku, takaokabuntan or Tamatama caused the inhibition of the microsomal CYP3A activity. The inhibition depended on the amount of a fruits juice added to the reaction mixture. Among the citrus fruits, banpeiyu juice showed the most potent inhibition. The addition of a banpeiyu juice (5.0%, v/v) resulted in the inhibition of midazolam 1Ј-hydroxylase activity of human CYP3A to about 20% of control without a fruit juice. The inhibition was weaker than that of grapefruit juice. The same amount of grapefruit juice (Tropicana-Kirin) caused the 99% inhibition of human CYP3A activity. No clear inhibition was observed with ama-natsu, Dekopon, hyuga-natsu and unshumikan.
We examined whether the component(s) of citrus fruits inhibited human CYP3A in a mechanism-based manner. If ingredient(s) was a mechanism-based inhibitor(s) of human CYP3A, we would expect the inhibition to be enhanced by preincubation of the ingredient(s) with the microsomal preparation. Results are shown in Table 2 . The inhibition potency of a fruit juice from banpeiyu or hassaku to the CYP3A activity observed with 15 min preincubation was higher than that observed with the 5 min preincubation. The residual activity seen with a fruit juice prepared from banpeiyu (5.0%, v/v) was 5% that seen with control without a fruit juice. The potency was somewhat lower than that observed with grapefruit juice (1.7%).
Judging from these results, we conclude that ingredient(s) of banpeiyu is inhibitor(s) or mechanism-based inhibitor(s) of human CYP3A activity, but the inhibitory effects are somewhat lower than those of grapefruit.
It is of interest to know what the component(s) of banpeiyu showing the inhibition or mechanism-based inhibition of human CYP3A is. It has been reported that the components of grapefruit which inhibited human CYP3A were extracted by ethyl acetate. 12) We preliminarily examined whether or not the ingredients of banpeiyu inhibiting the CYP3A activity were extracted by ethyl acetate. The banpeiyu juice (1 ml) was extracted by ethyl acetate (3 ml). The equivalent amount of the extract (5.0%, v/v) was incubated with human liver microsomes. The data obtained by us indicated that the components of banpeiyu showing the inhibition of CYP3A were not necessarily extracted by ethyl acetate. The residual activities of CYP3A were about 30% (5 min preincubation) and 24% (15 min preincubation), respectively. It seems likely that the component(s) of banpeiyu having the inhibitory effects on human CYP3A was different from that of grapefruit.
Interestingly, when the fruit juice prepared from Dekopon or unshu-mikan was added to the incubation mixture (2.5%, v/v), the CYP3A activity increased to 150% or 160%. CYP3A4 has been reported to exhibit not only the homotropic cooperativity but also the heterotropic cooperativity, which could influence drug metabolism and excretion or bioactivation. [16] [17] [18] [19] [20] Effectors such as a-naphthoflavone caused the stimulation of CYP3A4 activity toward some substrates.
16) The heterotropic cooperativity may be clinically significant due to the role, since it can play in enhancing drug-drug interaction. One of the emerging hypotheses of the mechanism of CYP3A4 cooperativity involves multiple substrate binding sites. 21, 22) A cooperative single-enzyme model with two binding sites where product can be formed either from the single-substrate-bound form or from the twosubstrate-bound form of the enzyme was described. 21, 22) The component(s) such as flavonoid(s) contained in Dekopon and unshu-mikan may also simultaneously bind to the active site of CYP3A enzyme with midazolam and may responsible for the heterotropic cooperativity which enhances the enzyme activity. 
